Biotronik | Jotup

PrepMD Partners with MediaSphere and Esteemed Cardiac Experts for Groundbreaking Virtual Device Clinic Leadership Summit

Retrieved on:

Wednesday, February 21, 2024

Consensus, FHRS, MSN, RN, Participation, HRS, Curriculum, Faculty, Heart Rhythm Society, CCDS, Business, Biotronik, Health, Journal, Atrium Health, Partnership

BRAINTREE, Mass., Feb. 21, 2024 /PRNewswire/ -- PrepMD, as the exclusive sponsor, is thrilled to announce its partnership with MediaSphere and distinguished cardiac professionals, including Beth Davenport and Sallie Gustafson, to present the largest-ever virtual accredited Cardiac Device Clinic Leadership Summit.

Key Points:

BRAINTREE, Mass., Feb. 21, 2024 /PRNewswire/ -- PrepMD, as the exclusive sponsor, is thrilled to announce its partnership with MediaSphere and distinguished cardiac professionals, including Beth Davenport and Sallie Gustafson, to present the largest-ever virtual accredited Cardiac Device Clinic Leadership Summit.
The summit aims to gather leading experts in cardiac device clinic management for a deep dive into pivotal topics.
The summit is privileged to feature a panel of esteemed faculty members, each recognized for their significant contributions to cardiac care:
Beth Davenport, MSN, RN, Clinical Translation Specialist at Biotronik (Former Director of Virtual Care and Cardiac Device Clinic, Sanger Heart & Vascular ), Charlotte, NC
Sallie Gustafson, RN, Manager of Device Clinic at Emory Clinic, Emory Healthcare , Atlanta, GA
Nancy Lee, RN, FHRS, CCDS, Regional Director of Device Operations, Clinical Arrhythmia Device Nurse, Prairie Cardiovascular Consultants, Ltd. , O'Fallon, IL
Amy Tucker, MSN, RN, CCDS, Nurse Manager, Cardiac Device Clinic, Sanger Heart & Vascular Institute , Charlotte, NC
The Device Clinic Summit is an essential event for all involved in cardiac device clinic management, offering a crucial forum for improving practices and patient care.
For registration and additional details, please visit the official website of the summit , hosted by The Journal of Innovations in Cardiac Rhythm Management™.

Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors

Retrieved on:

Wednesday, September 6, 2023

FORT LAUDERDALE, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and experiences, announced the appointment of Scott Durbin to the Company’s Board of Directors (the “Board”).

Key Points:

FORT LAUDERDALE, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and experiences, announced the appointment of Scott Durbin to the Company’s Board of Directors (the “Board”).
“We are excited to have Scott join our Board.
During this time, he established strong industry knowledge across the life sciences industry, including substantial therapeutic clinical development and global commercialization experience.
Prior to joining Vericel, Mr. Durbin was Chief Financial Officer, Chief Operating Officer and Secretary of Board at Prescient Medical.

Berlin Heals Holding AG welcomes Dr. Felix Baader and Roland Diggelmann as new board members Final phase of ongoing CE study started

Retrieved on:

Tuesday, August 22, 2023

Sonova, Heart, CE, Smith & Nephew, Heart failure, Biotronik, Quality of life, Certification, Hospital, Mettler Toledo, Patient, Roche, Philips, Medical device

ZUG, Switzerland, Aug. 22, 2023 /PRNewswire/ -- Berlin Heals Holding AG (Berlin Heals), a Swiss medical technology company, is delighted to announce the appointments of Dr. Felix Baader and Roland Diggelmann as new members of the Board of Directors.

Key Points:

ZUG, Switzerland, Aug. 22, 2023 /PRNewswire/ -- Berlin Heals Holding AG (Berlin Heals), a Swiss medical technology company, is delighted to announce the appointments of Dr. Felix Baader and Roland Diggelmann as new members of the Board of Directors.
We expect the ongoing CE certification study to confirm the excellent results of the pilot study; corresponding study results should be available approximately by the end of 2024.
Dr. Felix Baader commented: "I am honoured to be part of Berlin Heals' Board of Directors at this important stage.
As former CEO of Roche Diagnostics and British medtech company, Smith & Nephew, Mr. Diggelmann brings valuable know-how to Berlin Heals.

Berlin Heals Holding AG welcomes Dr. Felix Baader and Roland Diggelmann as new board members Final phase of ongoing CE study started

Retrieved on:

Tuesday, August 22, 2023

Sonova, Heart, CE, Smith & Nephew, Heart failure, Biotronik, Quality of life, Certification, Hospital, Mettler Toledo, Patient, Roche, Philips, Medical device

ZUG, Switzerland, Aug. 22, 2023 /PRNewswire/ -- Berlin Heals Holding AG (Berlin Heals), a Swiss medical technology company, is delighted to announce the appointments of Dr. Felix Baader and Roland Diggelmann as new members of the Board of Directors.

Key Points:

ZUG, Switzerland, Aug. 22, 2023 /PRNewswire/ -- Berlin Heals Holding AG (Berlin Heals), a Swiss medical technology company, is delighted to announce the appointments of Dr. Felix Baader and Roland Diggelmann as new members of the Board of Directors.
We expect the ongoing CE certification study to confirm the excellent results of the pilot study; corresponding study results should be available approximately by the end of 2024.
Dr. Felix Baader commented: "I am honoured to be part of Berlin Heals' Board of Directors at this important stage.
As former CEO of Roche Diagnostics and British medtech company, Smith & Nephew, Mr. Diggelmann brings valuable know-how to Berlin Heals.

Vektor Medical Welcomes Two New Advisors to Advance Technology and Commercial Development

Retrieved on:

Wednesday, April 26, 2023

She will support Vektor in its commercial development, growth planning, and leadership development.

Key Points:

She will support Vektor in its commercial development, growth planning, and leadership development.
“I’m thrilled to be joining Vektor’s advisory board to assist the team in the commercial roll-out of vMap.
I believe Vektor’s technology is poised to disrupt the market and greatly enhance the care of individuals affected by cardiac arrhythmias.
With their exceptional medical expertise and vast experience in electrophysiology, we are confident that they will provide invaluable insights and guidance to our team,” said Rob Krummen, CEO of Vektor Medical.

Patient Monitoring Devices Market Size to Reach USD 92.40 Billion in 2030 | Emergen Research

Retrieved on:

Tuesday, January 17, 2023

VANCOUVER, BC, Jan. 17, 2023 /PRNewswire/ -- The patient monitoring devices market size reached USD 47 Billion in 2021 and is expected to register a CAGR of 7.8% during the forecast period, according to latest analysis by Emergen Research .

Key Points:

VANCOUVER, BC, Jan. 17, 2023 /PRNewswire/ -- The patient monitoring devices market size reached USD 47 Billion in 2021 and is expected to register a CAGR of 7.8% during the forecast period, according to latest analysis by Emergen Research .
The patient monitoring devices market is expected to register a CAGR of 7.8% over the forecast period and revenue is projected to increase from USD 47.00 Billion in 2021 to USD 92.40 Billion in 2030. is expected to support revenue growth of the market.
The major factors for market expansion are the incidence of chronic diseases, favorable reimbursement circumstances, and rising awareness of patient monitoring devices.
Given the increasing research and development efforts by global market players to produce cutting-edge patient monitoring devices, the market revenue is expected to grow.

Patient Monitoring Devices Market Size to Reach USD 92.40 Billion in 2030 | Emergen Research

Retrieved on:

Tuesday, January 17, 2023

VANCOUVER, BC, Jan. 17, 2023 /PRNewswire/ -- The patient monitoring devices market size reached USD 47 Billion in 2021 and is expected to register a CAGR of 7.8% during the forecast period, according to latest analysis by Emergen Research .

Key Points:

VANCOUVER, BC, Jan. 17, 2023 /PRNewswire/ -- The patient monitoring devices market size reached USD 47 Billion in 2021 and is expected to register a CAGR of 7.8% during the forecast period, according to latest analysis by Emergen Research .
The patient monitoring devices market is expected to register a CAGR of 7.8% over the forecast period and revenue is projected to increase from USD 47.00 Billion in 2021 to USD 92.40 Billion in 2030. is expected to support revenue growth of the market.
The major factors for market expansion are the incidence of chronic diseases, favorable reimbursement circumstances, and rising awareness of patient monitoring devices.
Given the increasing research and development efforts by global market players to produce cutting-edge patient monitoring devices, the market revenue is expected to grow.

Cutter Law PC Announces $12.95 Million Settlement in Whistleblower Case Against Biotronik Alleging Kickbacks to Doctors

Retrieved on:

Thursday, July 28, 2022

Cutter Law PC announces that the international medical device company, Biotronik, Inc., has agreed to pay more than $12.95 million to the United States and various States to resolve claims that Biotronik unlawfully paid kickbacks to physicians.

Key Points:

Cutter Law PC announces that the international medical device company, Biotronik, Inc., has agreed to pay more than $12.95 million to the United States and various States to resolve claims that Biotronik unlawfully paid kickbacks to physicians.
18-cv-01391, was brought by two former Biotronik employees and whistleblowers who are clients of Cutter Law PC.
A settlement has subsequently been negotiated to resolve the claims of the United States and several states in exchange for a $12.95 million payment by Biotronik.
The whistleblowers were represented in the False Claims Act suit by John R. Parker, Jr. and his partner Brooks Cutter , founding member of Cutter Law PC.

Pharvaris Appoints Joan Schmidt, J.D., as Chief Legal Officer

Retrieved on:

Wednesday, May 11, 2022

In this role, she will lead all legal activities, including compliance and governance, in support of Pharvaris clinical drug development and commercialization strategies.

Key Points:

In this role, she will lead all legal activities, including compliance and governance, in support of Pharvaris clinical drug development and commercialization strategies.
Joan is a key new addition to our executive leadership team as her legal expertise draws on extensive experience advising biopharmaceutical companies that brought therapeutic products to market, said Berndt Modig, Chief Executive Officer of Pharvaris.
Joan will be integrally involved in executing Pharvaris business growth and strategic plans.
These forward-looking statements should not be relied upon as representing Pharvaris views as of any date subsequent to the date of this press release.

Assure Holdings Further Strengthens Clinical Team with Hiring of James Watt as National Technologist Director

Retrieved on:

Tuesday, April 26, 2022

DENVER, April 26, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (IONM) and remote neurology services, announced the appointment of James Watt to the position of national technologist director.

Key Points:

DENVER, April 26, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (IONM) and remote neurology services, announced the appointment of James Watt to the position of national technologist director.
Mr. Watt reports to Assures vice president of clinical operations, Stephanie Krouse.
In his new role, Mr. Watt leads day-to-day operations for Assures clinical technologist team, ensuring quality of service and overseeing the Companys training and development program.
Physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients neural structures throughout the procedure communicating in real-time with the surgeon and technologist.